Early postnatal growth in children with HLA-conferred susceptibility to type 1 diabetes

Diabetes/Metabolism Research and Reviews

Volumn 30, Issue 1, 2014, Pages 60-68

  Peet, Aleksandr ^b   Hämäläinen, Anu Maaria ^h   Kool, P ^a   Ilonen, Jorma ^d   Knip, Mikael ^f   Tillmann, Vallo ^b   Koski, Katriina ^f   Koski, Matti ^f   Ryhänen, Samppa ^f   Härkönen, Taina ^f   Ormisson, Anne ⁱ   Ulich, Valentina ^j   Kuzmicheva, Elena ^j   Mokurov, Sergei ^j   Markova, Svetlana ^k   Pylova, Svetlana ^k   Isakova, Marina ^l   Shakurova, Elena ^l   Petrov, Vladimir ^m   Dorshakova, Natalya V ⁿ   Karapetyan, Tatyana ⁿ   Varlamova, Tatyana ⁿ   Kiviniemi, Minna ^d   Alnek, Kristi ^a   Janson, Helis ^a   Uibo, Raivo ^a   Salum, Tiit ^o   von Mutius, Erika ^p   Weber, Juliane ^p   Ahlfors, Helena ^d   Kallionpää, Henna ^d   Laajala, Essi ^d   Lahesmaa, Riitta ^d   Lähdesmäki, Harri ^d   Moulder, Robert ^d   Nieminen, Janne ^q   Ruohtula, Terhi ^q   Vaarala, Outi ^q   Honkanen, Hanna ^r   Hyöty, Heikki ^r   Kondrashova, Anita ^r   Oikarinen, Sami ^r   Harmsen, Hermie J M ^s   De Goffau, Marcus C ^s   Welling, Gjal ^s   Alahuhta, Kirsi ^q   Virtanen, Suvi M ^q   more..

^a UNIVERSITY OF TARTU   (Estonia)

^b TARTU UNIVERSITY HOSPITAL   (Estonia)

^c UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TURKU   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

^h JORVI HOSPITAL   (Finland)

ⁱ TARTU UNIVERSITY HOSPITAL   (Estonia)

^j N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

^k Children's Republic Hospital Karelian Republic of the Russian Federation   (Russian Federation)

^l Perinatal Centre   (Russian Federation)

^m Maternity Hospital   (Russian Federation)

ⁿ PETROZAVODSK STATE UNIVERSITY   (Russian Federation)

^o Immunotron Ltd   (Estonia)

^p UNIVERSITY OF MUNICH   (Germany)

^q NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^r TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^s UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

more..

Author keywords

Environment; HLA DQ; Insulin resistance; Linear growth; Type 1 diabetes mellitus; Weight gain

Indexed keywords

HLA ANTIGEN;

ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ESTONIA; FEMALE; FINLAND; FOLLOW UP; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GROWTH CURVE; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; POSTNATAL GROWTH; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; WEIGHT GAIN;

ENVIRONMENT; HLA-DQ; INSULIN RESISTANCE; LINEAR GROWTH; TYPE 1 DIABETES MELLITUS; WEIGHT GAIN;

BODY HEIGHT; BODY WEIGHT; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE SUSCEPTIBILITY; ESTONIA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FINLAND; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GROWTH AND DEVELOPMENT; HLA ANTIGENS; HUMANS; INFANT; INSULIN RESISTANCE; MALE; SEX CHARACTERISTICS;

EID: 84892455632     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2449     Document Type: Article

References (41)

1. Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373: 2027-2033.
2. Vehik K, Hamman RF, Lezotte D, et al. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 2008; 31: 1392-1396.
3. Hermann R, Knip M, Veijola R, et al. Changes in the frequencies of HLA genotypes in patients with type 1 diabetes-indication of an increased environmental pressure? Diabetologia 2003; 46: 420-425.
4. Onkamo P, Vaananen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes-the analysis of the data on published incidence trends. Diabetologia 1999; 42: 1395-1403.
5. Åkerblom HK, Knip M. Putative environmental factors in type 1 diabetes. Diabetes Metab Rev 1998; 14: 31-67.
6. Dahlquist G. Environmental risk factors in human type 1 diabetes-an epidemiological perspective. Diabetes Metab Rev 1995; 11: 37-46.
7. Blom L, Persson LA, Dahlquist G. A high linear growth is associated with an increased risk of childhood diabetes mellitus. Diabetologia 1992; 35: 528-533.
8. Bognetti E, Riva MC, Bonfanti R, Meschi F, Viscardi M, Chiumello G. Growth changes in children and adolescents with short-term diabetes. Diabetes Care 1998; 21: 1226-1229.
9. Ljungkrantz M, Ludvigsson J, Samuelsson U. Type 1 diabetes: increased height and weight gains in early childhood. Pediatr Diabetes 2008; 9: 50-56.
10. EURODIAB Substudy 2 Study Group. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care 2002; 25: 1755-1760.
11. Hyppönen E, Virtanen SM, Kenward MG, Knip M, Akerblom HK, Childhood Diabetes in Finland Study Group. Obesity, increased linear growth, and risk of type 1 diabetes in children. Diabetes Care 2000; 23: 1755-1760.
12. Kibirige M, Metcalf B, Renuka R, Wilkin TJ. Testing the accelerator hypothesis: the relationship between body mass and age at diagnosis of type 1 diabetes. Diabetes Care 2003; 26: 2865-2870.
13. Knerr I, Wolf J, Reinehr T, et al. DPV scientific initiative of Germany and Austria. The 'accelerator hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9, 248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005; 48: 2501-2504.
14. Brown M, Ahmed ML, Clayton KL, Dunger DB. Growth during childhood and final height in type 1 diabetes. Diabet Med 1994; 11: 182-187.
15. Japan and Pittsburgh Childhood Diabetes Research Groups. Height at onset of insulin-dependent diabetes mellitus in high- and low-risk countries. Diabetes Res Clin Pract 1989; 6: 173-176.
16. DiLiberti JH, Carver K, Parton E, Totka J, Mick G, McCormick K. Stature at time of diagnosis of type 1 diabetes mellitus. Pediatrics 2002; 109: 479-483.
17. Songer TJ, LaPorte RE, Tajima N, et al. Height at diagnosis of insulin dependent diabetes in patients and their non-diabetic family members. Br Med J (Clin Res Ed) 1986; 292(6533): 1419-1422.
18. Leslie RD, Lo S, Millward BA, Honour J, Pyke DA. Decreased growth velocity before IDDM onset. Diabetes 1991; 40: 211-216.
19. Kharagjitsingh AV, de Ridder MA, Roep BO, Koeleman BP, Bruining GJ, Veeze HJ. Revisiting infant growth prior to childhood onset type 1 diabetes. Clin Endocrinol (Oxf) 2010; 72: 620-624.
20. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 2001; 44: 914-922.
21. Gale EA. Spring harvest? Reflections on the rise of type 1 diabetes. Diabetologia 2005; 48: 2445-2450.
22. Dahlquist G. Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia 2006; 49: 20-24.
23. Court S, Parkin M, Roberts DF, Wentzel J. HLA antigens and growth in diabetic children. Ann Hum Biol 1982; 9: 329-336.
24. Larsson HE, Hansson G, Carlsson A, et al. Children developing type 1 diabetes before 6years of age have increased linear growth independent of HLA genotypes. Diabetologia 2008; 51: 1623-1630.
25. Carlsson A, Kockum I, Lindblad B, et al. Swedish better diabetes diagnosis study group. Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the better diabetes diagnosis study in Sweden. Int J Obes (Lond) 2012; 36: 718-24.
26. Peet A, Kool P, Ilonen J, Knip M, Tillmann V, DIABIMMUNE Study Group. Birth weight in newborn infants with different diabetes-associated HLA genotypes in three neighbouring countries: Finland, Estonia and Russian Karelia. Diabetes Metab Res Rev 2012; 28: 455-461.
27. Griffin ME, Coffey M, Johnson H, et al. Universal vs. risk factor-based screening for gestational diabetes mellitus: detection rates, gestation at diagnosis and outcome. Diabet Med 2000; 17: 26-32.
28. WHO Multicentre Growth Reference Study Group. WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl 2006; 450: 76-85.
29. Kiviniemi M, Hermann R, Nurmi J, et al. A high-throughput population screening system for the estimation of genetic risk for type, 1 diabetes. An application for the TEDDY (the environmental determinants of diabetes in the young) study. Diabetes Technol Ther 2007; 9: 460-472.
30. Hermann R, Turpeinen H, Laine AP, et al. HLA DR-DQ encoded genetic determinants of childhood-onset type 1 diabetes in Finland. An analysis of 622 nuclear families. Tissue Antigens 2003; 62: 162-169.
31. Ilonen J. Genetic background of diabetes mellitus, type I. Duodecim 2004; 120: 1139-1145.
32. Smith DW, Truog W, Rogers JE, et al. Shifting linear growth during infancy: illustration of genetic factors in growth from fetal life through infancy. J Pediatr 1976; 89: 225-230.
33. Gillespie KM, Gale EA, Bingley PJ. High familial risk and genetic susceptibility in early onset childhood diabetes. Diabetes 2002; 51: 210-214.
34. Erlich H, Valdes AM, Noble J, et al. Type 1 diabetes genetics consortium. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 2008; 57: 1084-1092.
35. Teeäär T, Liivak N, Heilman K, et al. Increasing incidence of childhood-onset type 1 diabetes mellitus among Estonian children in 1999-2006. Time trend analysis 1983-2006. Pediatr Diabetes 2010; 11: 107-110.
36. Harjutsalo V, Sundr R, Knip M, Groop P-H. Long-awaited decrease in the incidence of type 1 diabetes in Finnish children under age 15. Diabetologia 2012; 55(Suppl 2): A237 (Abstract).
37. Ramachandran A, Snehalatha C, Joseph TA, Vijay V, Viswanathan M. Height at onset of insulin-dependent diabetes in children in southern India. Diabetes Res Clin Pract 1994; 23: 55-57.
38. Fourlanos S, Narendran P, Byrnes GB, Colman PG, Harrison LC. Insulin resistance is a risk factor for progression to type 1 diabetes. Diabetologia 2004; 47: 1661.
39. Xu P, Cuthbertson D, Greenbaum C, Palmer JP, Krischer JP, Diabetes Prevention Trial-Type 1 Study Group. Role of insulin resistance in predicting progression to type 1 diabetes. Diabetes Care 2007; 30: 2314-2320.
40. Mericq V, Ong KK, Bazaes R, et al. Longitudinal changes in insulin sensitivity and secretion from birth to age three years in small- and appropriate-for-gestational-age children. Diabetologia 2005; 48: 2609-2614.
41. Andersen MK, Lundgren V, Isomaa B, Groop L, Tuomi T. Association of variants in HLA-DQA1-DQB1, PTPN22, INS, and CTLA4 with GAD autoantibodies and insulin secretion in nondiabetic adults of the Botnia prospective study. Eur J Endocrinol 2012; 167: 27-33.